{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-135721","form_type":"8-K","ticker":"SPRY","cik":"0001671858","company_name":"ARS Pharmaceuticals, Inc.","filed_at":"2024-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.512586+00:00","generated_at":"2026-06-02T03:51:51.695288+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"ARS Pharmaceuticals updates corporate presentation; no specific new details disclosed","bullets":["Filed an updated corporate presentation for investor meetings on May 10, 2024.","Presentation available on company website; no material financial or operational updates provided.","No earnings, guidance, or pipeline changes mentioned in the filing text or exhibit title.","Investors should review the full presentation for any potential updates not summarized here."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-135721","json":"https://secwatch.observer/filing/0001193125-24-135721.json","markdown":"https://secwatch.observer/filing/0001193125-24-135721.md","text":"https://secwatch.observer/filing/0001193125-24-135721.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671858/000119312524135721/0001193125-24-135721-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671858/000119312524135721/d820291d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T03:51:51.695288+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}